OrganiGram Holdings (OGI)

OrganiGram Holdings (OGI) Stock Price & Analysis


OGI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.25 - $5.08
Previous Close$1.3
Average Volume (3M)619.04K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)C$52.73M
Total Debt (Recent Filing)C$180.00K
Price to Earnings (P/E)-0.6
Nov 27, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.04
Shares Outstanding80,492,622
10 Day Avg. Volume690,527
30 Day Avg. Volume619,041
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)0.57
Price to Sales (P/S)3.29
Price to Cash Flow (P/CF)-7.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside103.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4




What was OrganiGram Holdings’s price range in the past 12 months?
OrganiGram Holdings lowest stock price was $1.25 and its highest was $5.08 in the past 12 months.
    What is OrganiGram Holdings’s market cap?
    Currently, no data Available
    When is OrganiGram Holdings’s upcoming earnings report date?
    OrganiGram Holdings’s upcoming earnings report date is Nov 27, 2023 which is in 59 days.
      How were OrganiGram Holdings’s earnings last quarter?
      OrganiGram Holdings released its earnings results on Jul 14, 2023. The company reported -$1.966 earnings per share for the quarter, missing the consensus estimate of -$0.053 by -$1.913.
        Is OrganiGram Holdings overvalued?
        According to Wall Street analysts OrganiGram Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does OrganiGram Holdings pay dividends?
          OrganiGram Holdings does not currently pay dividends.
          What is OrganiGram Holdings’s EPS estimate?
          OrganiGram Holdings’s EPS estimate is -$0.1.
            How many shares outstanding does OrganiGram Holdings have?
            OrganiGram Holdings has 80,498,695 shares outstanding.
              What happened to OrganiGram Holdings’s price movement after its last earnings report?
              OrganiGram Holdings reported an EPS of -$1.966 in its last earnings report, missing expectations of -$0.053. Following the earnings report the stock price went down -19.588%.
                Which hedge fund is a major shareholder of OrganiGram Holdings?
                Currently, no hedge funds are holding shares in OGI


                OrganiGram Holdings Stock Smart Score

                The OrganiGram Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                OrganiGram Holdings

                OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.


                Top 5 ETFs holding OGI

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold OGI. The ETFs are listed according to market value of OGI within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Village Farms International
                HLS Therapeutics Inc
                DRI Healthcare

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis